Science Of Science Limited Filleted Accounts Cover |
Company No. 12414663 | |||||||||
Science Of Science Limited Directors Report Registrar |
The Director presents his report and the accounts for the year ended 31 January 2025. | |||||||||
Principal activities | |||||||||
Director | |||||||||
The Director who served at any time during the year was as follows: | |||||||||
D. Fanelli | |||||||||
Signed on behalf of the board | |||||||||
D. Fanelli | |||||||||
Director | |||||||||
18 April 2025 |
Science Of Science Limited Balance Sheet Registrar |
at | ||||||||||
Company No. | Notes | 2025 | 2024 | |||||||
£ | £ | |||||||||
Fixed assets | ||||||||||
Tangible assets | 4 | |||||||||
Current assets | ||||||||||
Cash at bank and in hand | ||||||||||
Creditors: Amount falling due within one year | 5 | ( | ( | |||||||
Net current assets | ||||||||||
Total assets less current liabilities | ||||||||||
Net assets | ||||||||||
Capital and reserves | ||||||||||
Called up share capital | ||||||||||
Profit and loss account | 7 | |||||||||
Total equity | ||||||||||
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on 18 April 2025 and signed on its behalf by: | ||||||||||
D. Fanelli | ||||||||||
Director | ||||||||||
18 April 2025 |
Science Of Science Limited Notes to the Accounts Registrar |
for the year ended 31 January 2025 | ||||||||||||||
1 | General information | |||||||||||||
Science Of Science Limited is a private company limited by shares and incorporated in England and Wales. | ||||||||||||||
Its registered number is: 12414663 | ||||||||||||||
Its registered office is: | ||||||||||||||
2 | Accounting policies | |||||||||||||
Turnover | ||||||||||||||
Revenue from the sale of goods is recognised when all the following conditions are satisfied: • the Company has transferred to the buyer the significant risks and rewards of ownership of the goods; • the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the economic benefits associated with the transaction will flow to the Company; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed. | ||||||||||||||
Tangible fixed assets and depreciation | ||||||||||||||
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. | ||||||||||||||
Plant and machinery | ||||||||||||||
Research and development costs | ||||||||||||||
Expenditure on research and development is written off in the year it is incurred unless it meets the criteria to allow it to be capitalised. Costs of research are always written off in the year in which they are incurred. Where development costs are recognised as an asset, they are amortised over the period expected to benefit from them. Amortisation of the capitalised costs begins once the developed product comes into use, typically at rate of 33.33% straight line. | ||||||||||||||
Trade and other debtors | ||||||||||||||
Trade and other creditors | ||||||||||||||
3 | Employees | |||||||||||||
2025 | 2024 | |||||||||||||
Number | Number | |||||||||||||
The average monthly number of employees (including directors) during the year was: | ||||||||||||||
4 | Tangible fixed assets | |||||||||||||
Plant and machinery | Total | |||||||||||||
£ | £ | |||||||||||||
Cost or revaluation | ||||||||||||||
At 1 February 2024 | ||||||||||||||
Additions | ||||||||||||||
At 31 January 2025 | ||||||||||||||
Depreciation | ||||||||||||||
At 1 February 2024 | ||||||||||||||
Charge for the year | ||||||||||||||
At 31 January 2025 | ||||||||||||||
Net book values | ||||||||||||||
At 31 January 2025 | ||||||||||||||
At 31 January 2024 | 658 | |||||||||||||
5 | Creditors: | |||||||||||||
amounts falling due within one year | ||||||||||||||
2025 | 2024 | |||||||||||||
£ | £ | |||||||||||||
Trade creditors | ||||||||||||||
Loans from directors | ||||||||||||||
Accruals and deferred income | ||||||||||||||
6 | Share Capital | |||||||||||||
1 ordinary share fully paid at £1 per share. | ||||||||||||||
7 | Reserves | |||||||||||||